Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 May;33(5):501-11.
doi: 10.1038/bjc.1976.81.

Response of remission lymphocytes to autochthonous leukaemic myeloblasts

Free PMC article

Response of remission lymphocytes to autochthonous leukaemic myeloblasts

G M Taylor et al. Br J Cancer. 1976 May.
Free PMC article

Abstract

Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Cancer. 1973 Mar;27(3):203-11 - PubMed
    1. Int J Cancer. 1973 Sep 15;12(2):409-19 - PubMed
    1. Int J Cancer. 1973 May;11(3):521-6 - PubMed
    1. Br Med J. 1973 Dec 8;4(5892):571-3 - PubMed
    1. Science. 1972 Sep 22;177(4054):1114-5 - PubMed